Clinical Trial Update: Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 Antibody [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating retreatment of non-Hodgkin lymphoma patients who previously responded to iodine-131 anti-B1 antibody; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Iodine-131 anti-B1 antibody (iodine-131 labeled anti-B1 antibody)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Non-Hodgkin | Phase 2 | Status: COMPLETED | Results posted: 2014-04-08